Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Translational Development Acquisition Corp. - Ordinary Shares (NQ:TDAC)

10.81 -0.02 (-0.16%)
Delayed Quote Updated: 3:45 PM EDT, Oct 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Translational Development Acquisition Corp. - Ordinary Shares

News headline image
Mercedes-Benz and ProLogium have entered into a joint testing agreement, including a preliminary technology evaluation of ProLogium’s latest Gen4 Superfluidized All Inorganic Solid State Battery Cell Technology
From ProLogium Technology Co., Ltd.
Via GlobeNewswire
News headline image
ProLogium Appoints Antony Sheriff, CEO of Rimac Group, to Board of Directors
Appointment intended to strengthen commercialization, scaling and cross-border governance capabilities as ProLogium prepares for its next stage of global growth 
From ProLogium Technology Co., Ltd.
Via GlobeNewswire
News headline image
Translational Development Investor Alert: Kahn Swick & Foti, LLC Investigates Translational Development Acquisition Corp. - TDAC
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination
From ProLogium Technology Co., Ltd.
Via GlobeNewswire
News headline image
ProLogium, a Next Generation Solid-State Battery Developer with 10+ Years of Proven Commercialization, to List on the Nasdaq through a Merger with Translational Development Acquisition Corp.
From ProLogium Technology Co., Ltd.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.